Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

BACKGROUND: Inhaled long-acting beta(2) agonists used alone and in combination with an inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD. However, the relative efficacy of these agents in preventing recurrent exacerbations in those recovering from an initial episod...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohar, Jill A, Crater, Glenn D, Emmett, Amanda, Ferro, Thomas J, Morris, Andrea N, Raphiou, Ibrahim, Sriram, Peruvemba S, Dransfield, Mark T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176847/
https://www.ncbi.nlm.nih.gov/pubmed/25248764
http://dx.doi.org/10.1186/s12931-014-0105-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176847/
https://www.ncbi.nlm.nih.gov/pubmed/25248764
http://dx.doi.org/10.1186/s12931-014-0105-2

Ejemplares similares